{"ticker": {"uuid": "e8a8abec-6856-4c97-9d97-a657c0ef4441", "symbol": "M1RN34", "name": "Moderna, Inc.", "exchange": "SAO", "country": "BR", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Could Arbutus Biopharma Corporation (ABUS) Turn its Moderna, Inc. (MRNA) Settlement Into a Lasting Biotech Advantage?", "summary": "A landmark legal settlement in the biotech sector recently reshaped the financial trajectories of two key mRNA technology players: Arbutus Biopharma Corporation (NASDAQ:ABUS) and Moderna, Inc. (NASDAQ:MRNA). The resolution of their global patent infringement litigation over lipid nanoparticle (LNP) delivery technology provided Arbutus with a massive, non-dilutive liquidity boost while removing a significant overhang for Moderna as it seeks to expand its commercial pipeline beyond COVID-19.Could Arbutus Biopharma Corporation (ABUS) Turn Its Moderna, Inc. (MRNA) Settlement Into a Lasting Biotech", "url": "https://finance.yahoo.com/healthcare/articles/could-arbutus-biopharma-corporation-abus-001821145.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-11T00:18:21+00:00", "published_display": "11 Aug 2026 00:18", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.247, "duplicate_count": 1, "topics": ["Balance Sheet", "Biotech", "Earnings", "Fda Approval", "Net Income", "Patent Settlement"]}, {"title": "RocketLab Rises on Space Interest; Moderna Moves on Flu Shot | Stock Movers", "summary": "On this episode of Stock Movers:- RocketLab (RKLB) shares are higher this morning after rising Friday, following earnings from SpaceX last week.- Moderna (MRNA) shares are moving after last week's news that its mRNA flu shot won US approval in an FDA turnaround.- Intel (INTC) shares are moving after the company said it will be offering $15 billion in common stock, taking advantage of renewed interest in its business prospects during the artificial intelligence data center boom. View Comments", "url": "https://finance.yahoo.com/video/rocketlab-rises-space-interest-moderna-151617251.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-10T15:16:17+00:00", "published_display": "10 Aug 2026 15:16", "sentiment": "positive", "sentiment_pct": 63, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.211, "duplicate_count": 1, "topics": ["Artificial Intelligence", "Earnings", "Fda Approval"]}], "by_tier": {"direct": [{"title": "Could Arbutus Biopharma Corporation (ABUS) Turn its Moderna, Inc. (MRNA) Settlement Into a Lasting Biotech Advantage?", "summary": "A landmark legal settlement in the biotech sector recently reshaped the financial trajectories of two key mRNA technology players: Arbutus Biopharma Corporation (NASDAQ:ABUS) and Moderna, Inc. (NASDAQ:MRNA). The resolution of their global patent infringement litigation over lipid nanoparticle (LNP) delivery technology provided Arbutus with a massive, non-dilutive liquidity boost while removing a significant overhang for Moderna as it seeks to expand its commercial pipeline beyond COVID-19.Could Arbutus Biopharma Corporation (ABUS) Turn Its Moderna, Inc. (MRNA) Settlement Into a Lasting Biotech", "url": "https://finance.yahoo.com/healthcare/articles/could-arbutus-biopharma-corporation-abus-001821145.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-11T00:18:21+00:00", "published_display": "11 Aug 2026 00:18", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.247, "duplicate_count": 1, "topics": ["Balance Sheet", "Biotech", "Earnings", "Fda Approval", "Net Income", "Patent Settlement"]}, {"title": "RocketLab Rises on Space Interest; Moderna Moves on Flu Shot | Stock Movers", "summary": "On this episode of Stock Movers:- RocketLab (RKLB) shares are higher this morning after rising Friday, following earnings from SpaceX last week.- Moderna (MRNA) shares are moving after last week's news that its mRNA flu shot won US approval in an FDA turnaround.- Intel (INTC) shares are moving after the company said it will be offering $15 billion in common stock, taking advantage of renewed interest in its business prospects during the artificial intelligence data center boom. View Comments", "url": "https://finance.yahoo.com/video/rocketlab-rises-space-interest-moderna-151617251.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-10T15:16:17+00:00", "published_display": "10 Aug 2026 15:16", "sentiment": "positive", "sentiment_pct": 63, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.211, "duplicate_count": 1, "topics": ["Artificial Intelligence", "Earnings", "Fda Approval"]}], "industry": [], "sector": []}, "total_fetched": 2, "total_unique": 2, "total_relevant": 2, "pipeline_health": {"providers_attempted": 1, "providers_with_results": 1, "raw_articles": 2, "unique_stories": 2, "duplicates_removed": 0, "relevant_stories": 2, "current_evidence": 2, "direct_evidence": 2, "eodhd_articles": 2, "eodhd": {"configured": true, "status": "running", "calls_used": 205, "call_budget": 500, "budget_used_pct": 41.0, "requests_made": 41, "last_success_at": "2026-08-13T05:45:20.147420+00:00", "newest_seen_at": "2026-08-13T05:26:00+00:00", "rate_limit": 1200, "rate_remaining": 1199, "last_error": "", "mapped_mentions": 3383, "unmapped_mentions": 1799}, "status": "healthy"}, "sentiment_summary": {"positive": 1, "negative": 1, "neutral": 0, "score": 49, "raw_score": 47, "total": 2, "evidence_count": 2, "effective_articles": 1.99, "direct_story_count": 2, "industry_story_count": 0, "sector_story_count": 0, "story_count": 2, "source_count": 1, "source_concentration": 1.0, "direct_share": 100, "dispersion": 15, "confidence": 51, "evidence_status": "measured", "score_version": "evidence-v4", "newest_article_at": "2026-08-11T00:18:21+00:00", "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "earnings", "primary_label": "Earnings", "confidence": 75, "events": [{"event": "earnings", "label": "Earnings", "weight": 1.2, "count": 2}], "positive_events": 1, "negative_events": 1, "pipeline": {"providers_attempted": 1, "providers_with_results": 1, "raw_articles": 2, "unique_stories": 2, "duplicates_removed": 0, "relevant_stories": 2, "current_evidence": 2, "direct_evidence": 2, "eodhd_articles": 2, "eodhd": {"configured": true, "status": "running", "calls_used": 205, "call_budget": 500, "budget_used_pct": 41.0, "requests_made": 41, "last_success_at": "2026-08-13T05:45:20.147420+00:00", "newest_seen_at": "2026-08-13T05:26:00+00:00", "rate_limit": 1200, "rate_remaining": 1199, "last_error": "", "mapped_mentions": 3383, "unmapped_mentions": 1799}, "status": "healthy"}}, "market_context": {"has_market_context": true, "latest_close": 14.73, "latest_week": "2026-08-07", "one_week_move": 5.3, "four_week_move": -14.4, "twelve_week_move": 17.8, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.059844, "market_dynamics_buy_signal": false, "relative_strength": 32.774145, "fair_value_gap": -10.4, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 49.8413, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+5.3% over one week, -14.4% over four weeks, trend active, and near fair-value range."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 49, "badges": [], "opportunities": [], "risks": [], "event_label": "Earnings", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "finance.yahoo.com", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 2}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Earnings", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "49/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Evidence confidence", "value": "51/100", "tone": "neutral", "text": "1.99 effective stories after overlap and weighting."}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Earnings", "tone": "neutral", "text": "75/100 classification confidence."}, {"label": "Company focus", "value": "2", "tone": "neutral", "text": "100% of weighted evidence is company-specific."}, {"label": "Evidence agreement", "value": "15/100", "tone": "positive", "text": "lower dispersion means the independent stories agree more closely."}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+5.3% over one week, -14.4% over four weeks, trend active, and near fair-value range."}, {"label": "Latest direct headline", "value": "Negative", "tone": "negative", "text": "Could Arbutus Biopharma Corporation (ABUS) Turn its Moderna, Inc. (MRNA) Settlement Into a Lasting Biotech Advantage?"}], "updated_at": "2026-08-13T06:00:27.500573+00:00", "detail_intelligence": {"headline": "Price moving ahead of tone", "summary": "Balanced news tone is drawn from 2 fresh independent stories, including 2 company-specific items across 1 publishers.", "status": "measured", "metrics": [{"label": "Weighted tone", "value": 49, "display": "49", "tone": "neutral", "note": "Balanced news tone"}, {"label": "Evidence confidence", "value": 51, "display": "51", "tone": "neutral", "note": "building confidence"}, {"label": "Company focus", "value": 100, "display": "100%", "tone": "positive", "note": "2 direct stories"}, {"label": "Evidence agreement", "value": 85, "display": "85", "tone": "positive", "note": "15/100 dispersion"}], "confidence_drivers": [{"label": "Sample depth", "value": 25, "note": "1.99 effective stories"}, {"label": "Source breadth", "value": 20, "note": "1 independent publishers"}, {"label": "Direct relevance", "value": 100, "note": "company-specific evidence share"}, {"label": "Freshness", "value": 67, "note": "recency-weighted evidence"}, {"label": "Agreement", "value": 85, "note": "cross-story consistency"}, {"label": "Source independence", "value": 0, "note": "lower publisher concentration"}], "freshness": 67, "source_independence": 0, "timeline": [{"date": "2026-07-24", "label": "24 Jul", "count": 0, "score": null, "tone": "neutral", "x": 42.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-25", "label": "25 Jul", "count": 0, "score": null, "tone": "neutral", "x": 87.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-26", "label": "26 Jul", "count": 0, "score": null, "tone": "neutral", "x": 133.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-27", "label": "27 Jul", "count": 0, "score": null, "tone": "neutral", "x": 179.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-28", "label": "28 Jul", "count": 0, "score": null, "tone": "neutral", "x": 225.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-29", "label": "29 Jul", "count": 0, "score": null, "tone": "neutral", "x": 271.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-30", "label": "30 Jul", "count": 0, "score": null, "tone": "neutral", "x": 316.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-31", "label": "31 Jul", "count": 0, "score": null, "tone": "neutral", "x": 362.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-01", "label": "01 Aug", "count": 0, "score": null, "tone": "neutral", "x": 408.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-02", "label": "02 Aug", "count": 0, "score": null, "tone": "neutral", "x": 454.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-03", "label": "03 Aug", "count": 0, "score": null, "tone": "neutral", "x": 500.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-04", "label": "04 Aug", "count": 0, "score": null, "tone": "neutral", "x": 545.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-05", "label": "05 Aug", "count": 0, "score": null, "tone": "neutral", "x": 591.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-06", "label": "06 Aug", "count": 0, "score": null, "tone": "neutral", "x": 637.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-07", "label": "07 Aug", "count": 0, "score": null, "tone": "neutral", "x": 683.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-08", "label": "08 Aug", "count": 0, "score": null, "tone": "neutral", "x": 729.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-09", "label": "09 Aug", "count": 0, "score": null, "tone": "neutral", "x": 774.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-10", "label": "10 Aug", "count": 1, "score": 63, "tone": "positive", "x": 820.6, "y": 111.3, "volume_height": 52.0, "volume_y": 214.0}, {"date": "2026-08-11", "label": "11 Aug", "count": 1, "score": 34, "tone": "negative", "x": 866.4, "y": 164.1, "volume_height": 52.0, "volume_y": 214.0}, {"date": "2026-08-12", "label": "12 Aug", "count": 0, "score": null, "tone": "neutral", "x": 912.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-13", "label": "13 Aug", "count": 0, "score": null, "tone": "neutral", "x": 958.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}], "timeline_points": "820.6,111.3 866.4,164.1", "timeline_has_signal": true, "timeline_start": "24 Jul", "timeline_mid": "03 Aug", "timeline_end": "13 Aug", "momentum": {"label": "Establishing", "tone": "neutral", "recent_score": 47, "prior_score": null, "delta": null, "recent_count": 2, "prior_count": 0, "volume_delta": 2}, "freshness_buckets": [{"label": "Last 24 hours", "count": 0, "share": 0}, {"label": "1 to 3 days", "count": 2, "share": 100}, {"label": "4 to 7 days", "count": 0, "share": 0}, {"label": "8 to 30 days", "count": 0, "share": 0}], "source_profile": [{"label": "finance.yahoo.com", "count": 2, "share": 100, "score": 47, "tone": "neutral"}], "event_profile": [{"label": "Earnings", "count": 2, "share": 100, "score": 47, "tone": "neutral"}], "topics": [{"label": "Fda Approval", "count": 2, "share": 100}, {"label": "Earnings", "count": 2, "share": 100}, {"label": "Patent Settlement", "count": 1, "share": 50}, {"label": "Net Income", "count": 1, "share": 50}, {"label": "Biotech", "count": 1, "share": 50}, {"label": "Balance Sheet", "count": 1, "share": 50}, {"label": "Artificial Intelligence", "count": 1, "share": 50}], "supporting": [{"label": "Direct evidence", "text": "2 current stories are mapped specifically to M1RN34."}, {"label": "Narrative agreement", "text": "Cross-story agreement is 85/100, indicating a comparatively coherent tape."}], "tempering": [{"label": "Source breadth", "text": "Only 1 publisher currently contribute to the measured read."}, {"label": "Price disagreement", "text": "Price is moving more forcefully than the current news tone suggests."}], "supporting_heading": "What supports the read", "tempering_heading": "What tempers the read", "latest_observation": {"title": "Could Arbutus Biopharma Corporation (ABUS) Turn its Moderna, Inc. (MRNA) Settlement Into a Lasting Biotech Advantage?", "summary": "A landmark legal settlement in the biotech sector recently reshaped the financial trajectories of two key mRNA technology players: Arbutus Biopharma Corporation (NASDAQ:ABUS) and Moderna, Inc. (NASDAQ:MRNA). The resolution of their global patent infringement litigation over lipid nanoparticle (LNP) delivery technology provided Arbutus with a massive, non-dilutive liquidity boost while removing a significant overhang for Moderna as it seeks to expand its commercial pipeline beyond COVID-19.Could Arbutus Biopharma Corporation (ABUS) Turn Its Moderna, Inc. (MRNA) Settlement Into a Lasting Biotech", "url": "https://finance.yahoo.com/healthcare/articles/could-arbutus-biopharma-corporation-abus-001821145.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-11T00:18:21+00:00", "published_display": "11 Aug 2026 00:18", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.25, "duplicate_count": 1, "topics": ["Balance Sheet", "Biotech", "Earnings", "Fda Approval", "Net Income", "Patent Settlement"]}, "article_count": 2, "updated_at": "2026-08-13T04:40:51.992589+00:00"}, "price_sentiment_path": {"available": true, "price_points": [{"x": 42.0, "y": 198.3, "label": "13 Feb 2026", "close": 11.52, "index": 100.0}, {"x": 78.6, "y": 181.0, "label": "20 Feb 2026", "close": 12.68, "index": 110.1}, {"x": 115.2, "y": 168.1, "label": "27 Feb 2026", "close": 13.55, "index": 117.6}, {"x": 151.9, "y": 169.4, "label": "06 Mar 2026", "close": 13.46, "index": 116.8}, {"x": 188.5, "y": 162.8, "label": "13 Mar 2026", "close": 13.91, "index": 120.7}, {"x": 225.1, "y": 171.7, "label": "20 Mar 2026", "close": 13.31, "index": 115.5}, {"x": 261.7, "y": 175.8, "label": "27 Mar 2026", "close": 13.03, "index": 113.1}, {"x": 298.3, "y": 176.3, "label": "03 Apr 2026", "close": 13.0, "index": 112.8}, {"x": 335.0, "y": 181.5, "label": "10 Apr 2026", "close": 12.65, "index": 109.8}, {"x": 371.6, "y": 173.1, "label": "17 Apr 2026", "close": 13.21, "index": 114.7}, {"x": 408.2, "y": 179.2, "label": "24 Apr 2026", "close": 12.8, "index": 111.1}, {"x": 444.8, "y": 204.2, "label": "01 May 2026", "close": 11.12, "index": 96.5}, {"x": 481.4, "y": 177.3, "label": "08 May 2026", "close": 12.93, "index": 112.2}, {"x": 518.1, "y": 183.7, "label": "15 May 2026", "close": 12.5, "index": 108.5}, {"x": 554.7, "y": 190.5, "label": "22 May 2026", "close": 12.04, "index": 104.5}, {"x": 591.3, "y": 188.3, "label": "29 May 2026", "close": 12.19, "index": 105.8}, {"x": 627.9, "y": 184.6, "label": "05 Jun 2026", "close": 12.44, "index": 108.0}, {"x": 664.5, "y": 179.2, "label": "12 Jun 2026", "close": 12.8, "index": 111.1}, {"x": 701.2, "y": 123.2, "label": "19 Jun 2026", "close": 16.57, "index": 143.8}, {"x": 737.8, "y": 112.4, "label": "26 Jun 2026", "close": 17.3, "index": 150.2}, {"x": 774.4, "y": 55.8, "label": "03 Jul 2026", "close": 21.11, "index": 183.2}, {"x": 811.0, "y": 113.7, "label": "10 Jul 2026", "close": 17.21, "index": 149.4}, {"x": 847.6, "y": 131.0, "label": "17 Jul 2026", "close": 16.05, "index": 139.3}, {"x": 884.3, "y": 167.5, "label": "24 Jul 2026", "close": 13.59, "index": 118.0}, {"x": 920.9, "y": 161.6, "label": "31 Jul 2026", "close": 13.99, "index": 121.4}, {"x": 957.5, "y": 150.6, "label": "07 Aug 2026", "close": 14.73, "index": 127.9}], "sentiment_points": [{"x": 705.5, "y": 130.0, "label": "19 Jun 2026", "score": 50}, {"x": 711.4, "y": 130.0, "label": "20 Jun 2026", "score": 50}, {"x": 712.6, "y": 130.0, "label": "21 Jun 2026", "score": 50}, {"x": 714.6, "y": 130.0, "label": "21 Jun 2026", "score": 50}, {"x": 717.8, "y": 130.0, "label": "22 Jun 2026", "score": 50}, {"x": 718.0, "y": 130.0, "label": "22 Jun 2026", "score": 50}, {"x": 718.9, "y": 130.0, "label": "22 Jun 2026", "score": 50}, {"x": 720.8, "y": 130.0, "label": "22 Jun 2026", "score": 50}, {"x": 721.4, "y": 130.0, "label": "22 Jun 2026", "score": 50}, {"x": 726.5, "y": 130.0, "label": "23 Jun 2026", "score": 50}, {"x": 733.0, "y": 130.0, "label": "25 Jun 2026", "score": 50}, {"x": 739.1, "y": 130.0, "label": "26 Jun 2026", "score": 50}, {"x": 739.5, "y": 130.0, "label": "26 Jun 2026", "score": 50}, {"x": 747.7, "y": 130.0, "label": "27 Jun 2026", "score": 50}, {"x": 770.5, "y": 130.0, "label": "02 Jul 2026", "score": 50}, {"x": 770.8, "y": 130.0, "label": "02 Jul 2026", "score": 50}, {"x": 773.0, "y": 130.0, "label": "02 Jul 2026", "score": 50}, {"x": 775.3, "y": 130.0, "label": "03 Jul 2026", "score": 50}, {"x": 786.6, "y": 130.0, "label": "05 Jul 2026", "score": 50}, {"x": 797.2, "y": 130.0, "label": "07 Jul 2026", "score": 50}, {"x": 798.0, "y": 130.0, "label": "07 Jul 2026", "score": 50}, {"x": 800.5, "y": 130.0, "label": "07 Jul 2026", "score": 50}, {"x": 820.2, "y": 130.0, "label": "11 Jul 2026", "score": 50}, {"x": 820.4, "y": 130.0, "label": "11 Jul 2026", "score": 50}, {"x": 820.7, "y": 130.0, "label": "11 Jul 2026", "score": 50}, {"x": 839.6, "y": 130.0, "label": "15 Jul 2026", "score": 50}, {"x": 841.8, "y": 130.0, "label": "15 Jul 2026", "score": 50}, {"x": 846.2, "y": 130.0, "label": "16 Jul 2026", "score": 50}, {"x": 857.6, "y": 130.0, "label": "18 Jul 2026", "score": 50}, {"x": 864.5, "y": 130.0, "label": "20 Jul 2026", "score": 50}, {"x": 875.7, "y": 130.0, "label": "22 Jul 2026", "score": 50}, {"x": 877.6, "y": 130.0, "label": "22 Jul 2026", "score": 50}, {"x": 877.7, "y": 130.0, "label": "22 Jul 2026", "score": 50}, {"x": 881.8, "y": 130.0, "label": "23 Jul 2026", "score": 50}, {"x": 882.4, "y": 130.0, "label": "23 Jul 2026", "score": 50}, {"x": 892.3, "y": 130.0, "label": "25 Jul 2026", "score": 50}, {"x": 892.5, "y": 130.0, "label": "25 Jul 2026", "score": 50}, {"x": 907.2, "y": 130.0, "label": "28 Jul 2026", "score": 50}, {"x": 907.8, "y": 130.0, "label": "28 Jul 2026", "score": 50}, {"x": 920.9, "y": 130.0, "label": "31 Jul 2026", "score": 50}, {"x": 934.4, "y": 130.0, "label": "02 Aug 2026", "score": 50}, {"x": 944.4, "y": 130.0, "label": "04 Aug 2026", "score": 50}, {"x": 949.5, "y": 130.0, "label": "05 Aug 2026", "score": 50}, {"x": 958.0, "y": 130.0, "label": "07 Aug 2026", "score": 50}], "price_path": "42.0,198.3 78.6,181.0 115.2,168.1 151.9,169.4 188.5,162.8 225.1,171.7 261.7,175.8 298.3,176.3 335.0,181.5 371.6,173.1 408.2,179.2 444.8,204.2 481.4,177.3 518.1,183.7 554.7,190.5 591.3,188.3 627.9,184.6 664.5,179.2 701.2,123.2 737.8,112.4 774.4,55.8 811.0,113.7 847.6,131.0 884.3,167.5 920.9,161.6 957.5,150.6", "sentiment_path": "705.5,130.0 711.4,130.0 712.6,130.0 714.6,130.0 717.8,130.0 718.0,130.0 718.9,130.0 720.8,130.0 721.4,130.0 726.5,130.0 733.0,130.0 739.1,130.0 739.5,130.0 747.7,130.0 770.5,130.0 770.8,130.0 773.0,130.0 775.3,130.0 786.6,130.0 797.2,130.0 798.0,130.0 800.5,130.0 820.2,130.0 820.4,130.0 820.7,130.0 839.6,130.0 841.8,130.0 846.2,130.0 857.6,130.0 864.5,130.0 875.7,130.0 877.6,130.0 877.7,130.0 881.8,130.0 882.4,130.0 892.3,130.0 892.5,130.0 907.2,130.0 907.8,130.0 920.9,130.0 934.4,130.0 944.4,130.0 949.5,130.0 958.0,130.0", "price_change": 27.9, "sentiment_change": 0, "latest_close": 14.73, "start_label": "13 Feb", "mid_label": "15 May", "end_label": "07 Aug"}, "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}